Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BMY
Recent news which mentions BMY
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
October 04, 2024
Tickers
BMY
NEWS
Tags
FDA
BMY
Biotech
From
Benzinga
2 Passive-Income Stocks to Load Up On in October
October 03, 2024
Tickers
BMY
LMT
Tags
BMY
Recent Press Releases
LMT
From
Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
October 01, 2024
Tickers
BMY
Tags
BMY
Markets
Options
From
Benzinga
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
October 01, 2024
Tickers
BMY
IGMS
NEWS
Tags
why it's moving
Market News
Benzinga
From
Benzinga
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
September 30, 2024
Tickers
BMY
PRME
Tags
PRME
Recent Press Releases
BMY
From
Motley Fool
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
September 30, 2024
Tickers
BMY
NEWS
PRME
Tags
General
Contracts
Movers
From
Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
September 28, 2024
Tickers
BMY
MRNA
PFE
Tags
MRNA
Recent Press Releases
BMY
From
Motley Fool
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Tickers
ABBV
BMY
NEWS
Tags
ABBV
Top Stories
Benzinga
From
Benzinga
14 Stocks Gain Momentum As August Inflation Comes In Below Expectations
September 27, 2024
Tickers
BABA
BHP
BMY
BP
Tags
LEN
Movers
News
From
Benzinga
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
September 27, 2024
Tickers
BMY
NEWS
PRTC
Tags
Market News
Benzinga
BMY
From
Benzinga
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
September 27, 2024
Tickers
ATCH
BMY
CDIO
DUO
Tags
NVNO
ONCO
SOAR
From
Benzinga
Wall Street On Wait-And-Watch Mode Ahead Of Inflation Data, Bitcoin Holds Above 65.5K: Analyst Says Volatility Ahead Providing Better Entry Point Into Long-term Bull Market
September 27, 2024
Tickers
BB
BITCOMP
BMY
COST
Tags
Futures
MU
Michelle Bowman
From
Benzinga
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
September 25, 2024
Tickers
BGNE
BMY
MRK
NEWS
Tags
Stories That Matter
Briefs
Health Care
From
Benzinga
Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability
September 25, 2024
Tickers
BMY
NEWS
NVO
TSVT
Tags
Benzinga
Top Stories
Market News
From
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Tickers
BHVN
BMY
BNTX
CI
Tags
JNJ
CI
TGTX
From
Benzinga
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
Tickers
ABBV
BMY
NEWS
Tags
Benzinga
Top Stories
ABBV
From
Benzinga
Bristol Myers Squibb Presents Data For Multiple Sclerosis Drug Zeposia, Shows Long-Term Efficacy
September 18, 2024
Tickers
BMY
NEWS
Tags
Briefs
Benzinga
Health Care
From
Benzinga
What Analysts Are Saying About Bristol-Myers Squibb Stock
September 16, 2024
Tickers
BMY
Tags
BMY
Analyst Ratings
Market News
From
Benzinga
3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade
September 16, 2024
Tickers
BEP
BMY
RPRX
Tags
Market News
Recent Press Releases
BMY
From
Motley Fool
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
September 14, 2024
Tickers
BMY
GILD
Tags
Recent Press Releases
BMY
Market News
From
Motley Fool
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
September 09, 2024
Tickers
BIIB
BMY
NEWS
Tags
Market News
healthcare
BIIB
From
Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
Tickers
AZN
BMY
ELVN
NEWS
Tags
Benzinga
Top Stories
PFE
From
Benzinga
2 Unstoppable Dividend Growth Stocks You Can Buy Now With $100
September 08, 2024
Tickers
BMY
RPRX
Tags
RPRX
BMY
Recent Press Releases
From
Motley Fool
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
September 06, 2024
Tickers
BMRN
BMY
GSK
LLY
Tags
GSK
General
News
From
Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Tickers
AMGN
AZN
BMY
JNJ
Tags
Media
General
News
From
Benzinga
2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time High
September 02, 2024
Tickers
BMY
Tags
BMY
Recent Press Releases
Market News
From
Motley Fool
2 No-Brainer Large-Cap Stocks to Buy With $500 Right Now
September 01, 2024
Tickers
BMY
HUBS
Tags
HUBS
BMY
Recent Press Releases
From
Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
August 30, 2024
Tickers
BMY
EIX
LUCY
O
Tags
Market News
dividens
Benzinga
From
Benzinga
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
August 28, 2024
Tickers
ABBV
BMY
NBIX
NEWS
Tags
Health Care
News
Movers
From
Benzinga
Kohl's Posts Upbeat Q2 Earnings, Joins Box, Waldencast, AeroVironment And Other Big Stocks Moving Higher On Wednesday
August 28, 2024
Tickers
AIXI
AMBA
AVAV
AVPT
Tags
AVPT
KSS
AIXI
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.